About this trial
This study aims at investigating if splinting and early mobilization is a better method, regarding range of motion, for treating fractures of the base phalanx of the fingers compared to surgery with pinning. This will be achieved through a randomised clinical trial comparing the two methods.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Fracture older than 2 weeks.
More than 25° of sagittal plane and/or 10° lateral angulation after reposition.
Intra-articular step >1mm.
Associated fractures in other bones (i e metacarpals, middle and distal phalanges) and/or tendon and nerve injuries in any finger.
Trial design
Parallel
Treatments tested in this trial
Percutaneous pinning
Procedure/SurgeryClosed reduction, percutaneous pinning and plaster
Conservative treatment
Procedure/SurgeryClosed reduction, custom made orthosis and early mobilization
Treatment groups
Trial outcomes
Primary outcomes
TAM (Total active range of motion)
Total active range of motion measured in degrees of the affected finger.
TAM (Total active range of motion)
Total active range of motion measured in degrees of the affected finger.
TAM (Total active range of motion)
Total active range of motion measured in degrees of the affected finger.
TAM (Total active range of motion)
Total active range of motion measured in degrees of the affected finger.
Secondary outcomes
Number of sick days
Number of sick days from the intervention until full return to work.
Patient related outcome measure DASH
Disability of the Arm, Shoulder and Hand score (DASH). 0 points means no disability and 100 maximum disability.
Patient related outcome measure HADS
Hospital Anxiety and Depression Scale (HADS). The score is consists of one depression scale from 0 to 21, where 0 is no signs of depression and one anxiety scale from 0 to 21, where 0 means no anxiety.
Patient related outcome measure EQ-5D
EuroQols quality of life index. Consists of an index based on the questionnaire where 0 means death and 1 means full quality of life and one visual analog scale 0-100 where patients rate their health from bad (0) to excellent (100).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.